2026.Aug.12
The Company’s BOD resolved to forfeit the subscription of OBIGEN Pharma’s cash capital increase and distribute the rights to its shareholders
Date of occurrence of the event:2026/08/12 Company name:OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office Reciprocal shareholding ratios:Not applicable Cause of occurrence:The Company’s shareholders’ general meeting resolved on June 27, 2023, to coordinate with OBIGEN Pharma’s future plan of business development, while protecting the shareholders’ interests, the Company may […]
This article is password protected.
To view the content, please enter your password in the field below